Cargando…

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status

We examined phosphorylated nuclear factor erythroid 2–related factor 2 (P‐NRF2) expression in surgically resected primary hepatocellular carcinoma (HCC) and investigated the association of P‐NRF2 expression with clinicopathological features and patient outcome. We also evaluated the relationship amo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iseda, Norifumi, Itoh, Shinji, Yoshizumi, Tomoharu, Tomiyama, Takahiro, Morinaga, Akinari, Yugawa, Kyohei, Shimokawa, Masahiro, Shimagaki, Tomonari, Wang, Huanlin, Kurihara, Takeshi, Kitamura, Yoshiyuki, Nagao, Yoshihiro, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Baba, Shingo, Ishigami, Kousei, Oda, Yoshinao, Mori, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948647/ https://www.ncbi.nlm.nih.gov/pubmed/34687175 http://dx.doi.org/10.1002/hep4.1838

Ejemplares similares

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
por: Yugawa, Kyohei, et al.
Publicado: (2021)

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
por: Tomiyama, Takahiro, et al.
Publicado: (2021)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
por: Nagao, Yoshihiro, et al.
Publicado: (2022)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

Solitary fibrous tumor in the liver: case report and literature review
por: Yugawa, Kyohei, et al.
Publicado: (2019)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

Liver resection with right hepatic vein reconstruction using the internal jugular vein: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2016)

Retroperitoneal schwannoma preoperatively diagnosed as liver metastasis from colon cancer: A case report
por: Wang, Huanlin, et al.
Publicado: (2019)

Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case report
por: Yoshida, Yoshihiro, et al.
Publicado: (2017)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
por: Itoh, S., et al.
Publicado: (2019)

A case of pseudoglandular hepatocellular carcinoma: The usefulness of a multimodal approach
por: Watanabe, Hirofumi, et al.
Publicado: (2018)

A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma
por: Shimagaki, Tomonari, et al.
Publicado: (2023)

DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples
por: Izumi, Takuma, et al.
Publicado: (2021)

Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma
por: Sugimachi, Keishi, et al.
Publicado: (2022)

Liver‐enriched transcription factor expression relates to chronic hepatic failure in humans
por: Guzman‐Lepe, Jorge, et al.
Publicado: (2018)

Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging
por: Takayama, Yukihisa, et al.
Publicado: (2021)

Laparoscopic liver resection in the semiprone position for tumors in the anterosuperior and posterior segments, using a novel dual-handling technique and bipolar irrigation system
por: Ikeda, Tetsuo, et al.
Publicado: (2014)

Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report
por: Omori, Sachie, et al.
Publicado: (2020)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report
por: Kurihara, Takeshi, et al.
Publicado: (2016)

Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy
por: Watanabe, Kenji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hh0j22fbeqvdpfr71lplnf2esc